First Trust Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

First Trust Capital Management’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$7.26M	Buy	+240,598	New	+$4.88M	2.67%	14

Other funds holding CPXX

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

First Trust Capital Management's CPXX Position: Q2 2016 in Review

First Trust Capital Management opened a new position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q2 2016: 240,598 shares worth $7.26M. The stake represents 2.67% of the portfolio and ranks #14 among its holdings.

119 funds tracked by Wall St. Rank hold CPXX as of Q2 2016.

First Trust Capital Management held 240,598 shares of CELATOR PHARMACEUTICALS INC. COMMON STOCK worth $7.26M as of Q2 2016.
CELATOR PHARMACEUTICALS INC. COMMON STOCK was a new First Trust Capital Management position in Q2 2016.
CELATOR PHARMACEUTICALS INC. COMMON STOCK made up 2.67% of First Trust Capital Management's portfolio in Q2 2016, its #14 holding.
119 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q2 2016.

Based on First Trust Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.